COVID-19疫苗接种和绝经后出血:一个回顾性队列研究
Lucía Pastor-Goutherot1, Ester Miralpeix1,2, Berta Fabregó2
1Pompeu Fabra University, Barcelona, Spain.
Climacteric : the journal of the International Menopause Society
|August 12, 2024
概括
接种COVID-19疫苗与更高的绝经后出血 (PMB) 发生率有关. 然而,该疫苗并没有增加子宫内膜癌症的风险,尽管建议对任何PMB进行子宫内膜活检.
科学领域:
- 妇科 妇科 妇科 妇科
- 生殖健康 生殖健康
- 疫苗学 疫苗学 疫苗学
背景情况:
- 在接种COVID-19疫苗后,有报道月经不规则.
- 接种COVID-19疫苗对绝经后妇女的影响,特别是对于绝经后出血 (PMB),仍然在很大程度上是未知的.
- 了解广泛疫苗接种计划的潜在副作用对于公共卫生至关重要.
研究的目的:
- 为了调查接受COVID-19疫苗接种后女性的绝经后出血 (PMB) 的患病率.
- 分析COVID-19疫苗接种和PMB发生在绝经后队列之间的关联.
- 评估子宫内膜病理与疫苗接种状态和PMB相关的情况.
主要方法:
- 一项回顾性研究包括381名绝经后妇女,分为接种疫苗 (n=91) 和未接种疫苗 (n=290) 组.
- 数据是在2021年2月至2022年1月期间收集的,PMB被定义为疫苗接种后30天以上发生的出血.
- 进行了统计分析,包括单变量和多变量回归,以确定PMB的风险因素.
主要成果:
- 疫苗接种组的PMB患病率明显高 (75.8%) 与未接种疫苗的组相比 (59.0%) (p < 0.005).
- 在接种疫苗的组中没有观察到恶性子宫内膜病理的统计显著增加 (p = 0.189).
- 多变量分析确定了COVID-19疫苗接种和恶性子宫内膜活检作为PMB的独立风险变量.
结论:
- 接种COVID-19疫苗与更年期后出血的患病率增加有关.
- 虽然接种疫苗与恶性子宫内膜病理的风险增加无关,但PMB需要进一步调查.
- 宫内膜活检仍然是评估绝经后出血的关键诊断工具,无论接种疫苗的情况如何.
相关概念视频
Menopause
146
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
146
Disorders of the Female Reproductive System
340
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
340
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124


